In 2020, there were more recalls for drugs and medical devices than there were in 2019. This continued the trend that has been going on for years. For example, there were more medical devices recalled in 2019 than in each of the previous four years.…
In June 2020, Janssen Pharmaceuticals changed the warnings on the product label for the U.S. versions of interstitial cystitis (IC) drug Elmiron (pentosan polysulfate sodium or PPS). The new warnings alerted doctors and patients to the potential risk of vision damage. Many American consumers, howeve
The U.S. Food and Drug Administration (FDA) recently announced the recall of all Boston Scientific LOTUS Edge Aortic Valve Systems. These systems are comprised of two separate parts, one being the valve and the other the delivery system. These devices are used to treat patients…
Retinal vasculitis is an inflammatory condition affecting the blood vessels in the retina of the eye. It usually occurs in association with another disease like lupus or Behcet’s syndrome, but recent studies suggest it may also be associated with the prescription drug Beovu (brolucizumab), which…
In June 2019, online pharmacy Valisure detected a cancer-causing agent (NDMA) in the popular heartburn drug Zantac (ranitidine). Since then, thousands of consumers have been concerned that if they took the drug—particularly if they took it for long periods—they may now be at an increased…
When Bayer announced in July 2018 that it would stop selling the permanent birth control device Essure, the U.S. Food and Drug Administration (FDA) required the company to continue to evaluate long-term safety information in women who received the device. According to the latest analysis…
A Florida man has recently joined the Zantac MDL proceeding in the U.S. District Court for the District of Southern Florida. He filed a short-form complaint alleging that he developed cancer after using Zantac for several years. The U.S. Judicial Panel on Multidistrict Litigation (JPML)…
In June 2020, Janssen Pharmaceuticals, which manufactures the interstitial cystitis (IC) drug Elmiron, updated the warning label on the medication, alerting patients and doctors of the potential risk of vision damage. Unfortunately, there is evidence that suggests that the drug manufacturer knew or
The U.S. Food and Drug Administration (FDA) approved the prescription drug Beovu (brolucizumab-dbll) in October 2019 for the treatment of wet age-related macular degeneration (AMD), a serious eye disease. Recent research, however, has suggested that patients taking the drug may have a slightly incre
Patients suffering from wet age-related macular degeneration (AMD) who have been treated with the drug Beovu (brolucizumab) may be at an increased risk for another type of vision loss. Though the drug is designed to treat and prevent further vision loss, recent research has suggested…
On September 12, 2019, the FDA first alerted the public to the possible presence of cancer-causing N-nitrosodimethylamine (NDMA) in Zantac and generic ranitidine medications. Since then, drug manufacturers have faced an increasing number of Zantac lawsuits filed against them in courts across the co
Since the COVID-19 pandemic hit in early 2020, many small businesses have suffered significant losses due to the resulting government shutdowns. To recover at least some of those losses, hundreds have filed claims with their business insurance companies, but so far, most of those companies…
